FasPsych Revenue and Competitors

Claim your profile

Phoenix, AZ USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • FasPsych's estimated annual revenue is currently $34M per year.(i)
  • FasPsych's estimated revenue per employee is $270,000

Employee Data

  • FasPsych has 126 Employees.(i)
  • FasPsych grew their employee count by 15% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$22.7M840%N/AN/A

keywords:Healthcare,Healthcare Providers

N/A

Total Funding

126

Number of Employees

$34M

Revenue (est)

15%

Employee Growth %

N/A

Valuation

N/A

Accelerator

FasPsych News

2022-04-17 - Telepsychiatry Market 2022 Scale, (Sales and Revenue ...

FasPsych ? Genoa ? Encounter Telehealth ? Arcadian Telepsychiatry ? InnovaTel. Market Segments by Type: ? Routine Telepsychiatry

2022-04-17 - Global Telepsychiatry Market 2022 – Opportunities, Key ...

InSight Telepsychiatry, American Telepsychiatrists, Iris Telehealth, JSA Health, Advanced Telemed Services, FasPsych, Genoa,...

2019-09-08 - Global Telepsychiatry Market Growing Demand to Impact Revenue Share during 2019-2025| American Telepsychiatrists, Iris Telehealth, JSA Health, Advanced Telemed Services, FasPsych, Genoa, Encounter

Key players are InSight Telepsychiatry, American Telepsychiatrists, Iris Telehealth, JSA Health, Advanced Telemed Services, FasPsych, Genoa ...

2019-09-03 - Global Telepsychiatry Market (2019-2024) Demand Analysis, by Key Players, opportunities and explorative solutions in this competitive domain .

Telepsychiatry, American Telepsychiatrists, JSA Health, Advanced Telemed Services, FasPsych, Genoa, Encounter Telehealth, Arcadian ...

2019-09-03 - Telepsychiatry Market 2019 (CAGR – 22.6%)- Iris Telehealth ...

... Iris Telehealth, JSA Health, Advanced Telemed Services, FasPsych, Genoa, Encounter Telehealth, Arcadian Telepsychiatry, InnovaTel.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$300M1260%N/A
#2
$44.8M12714%N/A
#3
$30.4M127-12%N/A
#4
$19.1M12713%N/A
#5
$30.6M128-1%$10M